Ovid Therapeutics Announces Workforce Reduction to Extend Runway
Company Announcements

Ovid Therapeutics Announces Workforce Reduction to Extend Runway

An announcement from Ovid Therapeutics (OVID) is now available.

Ovid Therapeutics Inc. is slashing its workforce by 43% to streamline operations and extend its financial horizon. The cut affects 17 employees, who will receive severance and health insurance benefits post-termination, incurring an estimated one-time cost of $4 million for the company. This move is anticipated to be largely finalized by the end of the third quarter of 2024, with most cash payouts completed by the second quarter of 2025. Additionally, two executives will depart, with possible consulting roles to ease the transition. These efforts are expected to sustain the company’s cash flow into the first half of 2026.

Learn more about OVID stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyOvid Therapeutics reports Q3 EPS (20c), consensus (20c)
TheFlyOvid Therapeutics presents study results on OV329
TipRanks Auto-Generated NewsdeskOvid Therapeutics Elevates Meg Alexander to President and COO
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App